Sinsin Pharmaceutical Co. Ltd (002800) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.066x

Based on the latest financial reports, Sinsin Pharmaceutical Co. Ltd (002800) has a cash flow conversion efficiency ratio of 0.066x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.70 Billion ≈ $3.18 Million USD) by net assets (₩71.01 Billion ≈ $48.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Sinsin Pharmaceutical Co. Ltd (002800) balance sheet quality index to measure how much of total assets are equity-financed.

Sinsin Pharmaceutical Co. Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Sinsin Pharmaceutical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Sinsin Pharmaceutical Co. Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Sinsin Pharmaceutical Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sinsin Pharmaceutical Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
S P V I Public Company Limited BK:SPVI	0.102x
Li Cheng Enterprise Co Ltd TW:4426	-0.022x
Dgenx Co. Ltd KQ:113810	0.073x
Daeryuk Can Co. Ltd KQ:004780	0.026x
SKY LIGHT HOLDINGS LTD F:27L	N/A
VirnetX Holding Corp Common Stock NASDAQ:VHC	-0.228x
Stalprofil S.A. WAR:STF	0.114x
Surapon Foods Public Company Limited BK:SSF	0.082x

Annual Cash Flow Conversion Efficiency for Sinsin Pharmaceutical Co. Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Sinsin Pharmaceutical Co. Ltd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see Sinsin Pharmaceutical Co. Ltd (002800) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩65.87 Billion ≈ $44.64 Million	₩5.94 Billion ≈ $4.03 Million	0.090x	+42.55%
2023-12-31	₩62.09 Billion ≈ $42.08 Million	₩3.93 Billion ≈ $2.66 Million	0.063x	-30.80%
2022-12-31	₩59.70 Billion ≈ $40.46 Million	₩5.46 Billion ≈ $3.70 Million	0.091x	+21570.98%
2021-12-31	₩54.93 Billion ≈ $37.22 Million	₩23.18 Million ≈ $15.71K	0.000x	-98.73%
2020-12-31	₩56.20 Billion ≈ $38.08 Million	₩1.87 Billion ≈ $1.26 Million	0.033x	+141.52%
2019-12-31	₩56.36 Billion ≈ $38.20 Million	₩-4.51 Billion ≈ $-3.05 Million	-0.080x	-663.11%
2018-12-31	₩54.54 Billion ≈ $36.96 Million	₩774.24 Million ≈ $524.69K	0.014x	-83.80%
2017-12-31	₩52.12 Billion ≈ $35.32 Million	₩4.57 Billion ≈ $3.10 Million	0.088x	+8.00%
2016-12-31	₩34.43 Billion ≈ $23.33 Million	₩2.79 Billion ≈ $1.89 Million	0.081x	--

About Sinsin Pharmaceutical Co. Ltd

KQ:002800 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$43.39 Million

₩64.02 Billion KRW

Market Cap Rank

#22387 Global

#1391 in Korea

Share Price

₩4220.00

Change (1 day)

+1.93%

52-Week Range

₩4015.00 - ₩6630.00

All Time High

₩13396.03